In this article, we describe three broad pathologic presentations of plasmacytoid dendritic
cells (pDCs) that may be encountered in clinical practice, in which an association between …

Plasmacytoid dendritic cells (pDCs) are type I interferon-producing cells that modulate
immune responses. There are two types of pDC neoplasms: 1) mature pDC proliferation …

Plasmacytoid dendritic cells (pDCs) are the principal natural type I interferon–producing
dendritic cells. Neoplastic expansion of pDCs and pDC precursors leads to blastic …

Abstract Purpose of Review The purpose of this review was to summarize the clinical,
diagnostic, and therapeutic features of blastic plasmacytoid dendritic cell neoplasm …

Acute myeloid leukemia (AML) is a genetically and clinically heterogeneous disease. Gene
mutational and expressional profile can aid the identification of different prognostic …

This report highlights the value of flow cytometry analysis, particularly in the setting of
myeloproliferative neoplasms showing features of progression, as neoplastic plasmacytoid …

Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is an aggressive neoplasm derived
from plasmacytoid dendritic cells (pDCs). In this study, we investigated by …

Acute myeloid leukemia with biallelic mutation of CEBPA (CEBPA-dm AML) is a distinct
good prognosis entity recognized by WHO 2016 classification. However, testing for CEBPA …

Overexpression of microRNA-99a (miR-99a) have been associated with adverse prognosis
in acute myeloid leukemia (AML). Nevertheless, whether it also predicts poor outcome in …

Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare and aggressive myeloid
malignancy which characteristically expresses an atypical phenotype including CD123+ …